PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China.\', \'Institute of Health Management, Health Management Center, Sichuan Provincial People\'s Hospital, University of Electronic Science and Technology of China, 611731, Chengdu, China.\', \'Shenzhen Laboratory of Human Antibody Engineering, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 518055, Shenzhen, China.\', \'Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, 100005, Beijing, China.\', \'Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.\', \'Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, 450052, Zhengzhou, China. yizhang@zzu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41392-020-00243-2
?:doi
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 32712629
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19: immunopathogenesis and Immunotherapeutics.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all